Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | VCYT Veracyte, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $39.80 -1.9% | $15.06 -2.0% |
| StockIQ Score | 50C- Moderate Risk: High | 36F Weak Risk: Medium |
| Technical | 7F | 13F |
| Fundamental | 59C | 35F |
| Growth | 79B+ | 50C- |
| Fair Value | 45D+ | 38F |
| News | 98A+ | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Veracyte (VCYT) outperforms Ascentage Pharma (AAPG) in most metrics, with higher investor (53 vs 35), technical (29 vs 13), fundamental (59 vs 35) and growth scores (79 vs 50). AAPG has a marginally better valuation score (38 vs 33). Overall VCYT shows stronger scores except valuation.